Insiders Buy as Sellers Dominate Asia

The most recent insider data available from ORTEX covers filings up to September 8, 2026. US-specific SEC EDGAR Form 4 tables were not accessible in this session, so the largest open-market trades by named C-suite executives at US-listed companies could not be retrieved directly.

From the data that was gathered, the dominant story is JPMorgan Chase trimming positions across multiple Hong Kong-listed names. The bank filed disclosures on September 8 showing it sold shares in Kingdee International Software (268) worth $84.9m, Sunny Optical (2382) for $70.8m, and ZTO Express (2057) for $28.4m, all on September 2. These are 5% owner threshold filings, not discretionary C-suite trades, so they carry limited directional signal.

The clearest buy signal in the dataset came from a chairman. At Turkish industrial valve maker BURVA, chairman Umit Gumus filed a purchase of 1.07 million shares worth $12.9m on September 7, the same day an asset manager sold a near-identical $13.6m block. The opposing moves suggest a direct ownership transfer rather than fresh conviction.

One genuinely noteworthy buy: JPMorgan picked up 18.2 million shares in Pharmaron Beijing (3759) for $66.2m on September 2, crossing the 10% ownership threshold. That is a passive custodial adjustment in most cases, but the scale stands out.

On the US screening side, LEN (Lennar) and CRWD (CrowdStrike) showed the largest insider selling volumes over the past month by EUR value. CrowdStrike is down 49% year-to-date, making the selling notable. Full Form 4 detail for those trades was unavailable in this session.

Note: US SEC EDGAR Form 4 tables were not accessible. Full open-market buy/sell detail for US-listed executives could not be retrieved.